MedTrace Logo

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

NCT03743688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-08-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the body's immune response at different time points to an FDA-approved seasonal influenza vaccine. By better understanding the way the immune system responds to the influenza vaccine, the investigators can design more effective vaccines against influenza.

Conditions

  • Influenza
  • Influenza, Human
  • Vaccine Reaction
  • Influenza A
  • Influenza Type B
  • Influenza A H1N1
  • Influenza A H3N2

Interventions

BIOLOGICAL

Influenza Vaccine Recipients

0.5 mL intramuscular injection

Sponsors & Collaborators

  • Human Vaccines Project

    collaborator OTHER

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Buddy Creech, MD, MPH · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-04
Primary Completion
2019-07-26
Completion
2019-07-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743688 on ClinicalTrials.gov